Journal of Assisted Reproduction and Genetics

, Volume 11, Issue 2, pp 85–91 | Cite as

Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques

  • B. C. Tarlatzis
  • G. Grimbizis
  • F. Pournaropoulos
  • J. Bontis
  • S. Lagos
  • G. Pados
  • S. Mantalenakis
Clinical Assisted Reproduction



The administration of two GnRH analogues (buserelin and leuprolide acetate) in long and short protocols was evaluated prospectively. In the long protocol, the analogues were given from day 1 of the cycle for at least 14 days and then hMG administration was started, while in the short protocol the analogues were initiated from cycle day 1, adding hMG from day 3. The patients were divided into four groups according to the protocol used: Group I, buserelin-long; Group II, buserelin-short; Group III, leuprolide-long; and Group IV, leuprolide-short. Serum E2levels on the day of hCG injection and the number of follicles observed, oocytes retrieved, and embryos obtained, as well as implantation rates, were significantly higher (P<0.001) in the long protocols than in the short ones.


Pregnancy rates were similar in all groups, although a trend for better results was observed in buserelin-long compared to buserelin-short. There were no differences in the results achieved with buserelin or leuprolide.


The administration of GnRH analogues (buserelin and leuprolide acetate) in long protocols induced a more intense ovarian response and was associated with significantly higher implantation rates and also a trend for higher pregnancy rates, although this difference was not statistically significant.

Key words

ovarian stimulation gonadotropin-releasing hormone analogues buserelin leuprolide 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Smitz J, Ron-El R, Tarlatzis BC: The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: Experience from three centers. Hum Reprod 1992;7(Suppl 1):49–66Google Scholar
  2. 2.
    Zeevi D, Younis SJ, Laufer N: Ovulation induction—New approaches. Assist Reprod Rev 1991;1:2–8Google Scholar
  3. 3.
    Testart J, Plachot M, Mandelbaum J, Salat-Baroux J, Frydman R, Cohen J: World collaborative report on IVF-ET and GIFT: 1989 results. Hum Reprod 1992;7:362–369PubMedGoogle Scholar
  4. 4.
    Testart J, Lefevre B, Gougeon A: Effects of gonadotrophinreleasing hormone agonists (GnRH-a) on follicle and oocyte quality. Hum Reprod 1993;8:511–518PubMedGoogle Scholar
  5. 5.
    Barrière P, Lopes P, Boiffart J-P, Pousset C, Quentin M, Sagot P, L'Hermite A, Levat MF, Charbonnel B: Use of GnRH analogues in ovulation induction for in vitro fertilization. Benefits of a short administration regimen. J Vitro Fertil Embryo Transfer 1987;4:64–65CrossRefGoogle Scholar
  6. 6.
    Smitz J, Devroey P, Broekmans P, Camus M, Khan I, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC: Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analog and hMG. Hum Reprod 1987;2:309–314PubMedGoogle Scholar
  7. 7.
    Tarlatzis BC, Bili H: LH-RH analogues and follicular fluid in IVF cycles. Releaser 1992;7(2):3–7Google Scholar
  8. 8.
    Latouche J, Coumeyrolle-Arias M, Jordan D, Kopp N, Augendre-Ferrante B, Cedard L, Haour F: GnRH receptors in human granulosa cells: Anatomical localization and characterization by autoradiographic study. Endocrinology 1989;125:1739–1741PubMedGoogle Scholar
  9. 9.
    Parinaud J, Beaur A, Bourreau M, Vieitez G, Pontonnier G: Effect of a LHRH agonist (buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil Steril 1988;50:597–602PubMedGoogle Scholar
  10. 10.
    Bramley T, Menzies G, Baird D: Specificity of GnRH binding sites of human corpus luteum: Comparison with receptors of rat pituitary gland. J Endocrinol 1986;108:323–328PubMedGoogle Scholar
  11. 11.
    Tarlatzis BC, Pados G, Bontis J, Lagos S, Grimbizis G, Spanos E, Mantalenakis S: Ovarian stimulation with Buserelin/ hMG/hCG: Prospective randomised study of short versus long protocol. Hum Reprod 1993;8:807–812PubMedGoogle Scholar
  12. 12.
    Tarlatzis BC, Grimbizis G: Assisted reproduction techniques in polycystic ovarian syndrome. Ann NY Acad Sci 1993;687:280–287PubMedGoogle Scholar
  13. 13.
    Tarlatzis BC: Oocyte collection and quality. Assist Reprod Rev 1992;2:16–22Google Scholar
  14. 14.
    Hedon B, Arnal F, Basor E, Boulot P, Huet JM, Fries N, Deschamps F, Cristal P, Humeau C: Comparaison randomisée protocole long-protocole court dans les stimulations de l'ovaire en association avec un agoniste de la GnRH en vue de fecondation in vitro. Contracept Fertil Sexual 1988;16:624–627Google Scholar
  15. 15.
    Tan SL, Kingsland C, Cambell S, Mills C, Bradfield J, Alexander N, Yovich J, Jacobs HS: The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810–814PubMedGoogle Scholar
  16. 16.
    Remorgida V, Anserini P, Crose S, Costa M, Ferrailo A, Centonze A, Gaggero G, Capitanio G: The duration of pituitary suppression by means of intranasal gonadotropin-releasing hormone administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program. J Vitro Fertil Embryo Transfer 1989;6:76–80CrossRefGoogle Scholar
  17. 17.
    Frydman R, Parneix I, Bellaish-Allart J, Forman R, Hazout A, Fernandez H, Testart J: LHRH agonists in IVF: different methods of utilization and comparison with previous ovulation stimulation treatments. Hum Reprod 1988;3:559–561PubMedGoogle Scholar
  18. 18.
    Acharya U, Small J, Randall J, Hamilton M, Templeton A: Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program. Fertil Steril 1992;57:815–818PubMedGoogle Scholar
  19. 19.
    Meldrum D, Steingold K, de Ziegler D, Chetkowski R, Hamilton F, Randle D: Influence of the resting state of the ovary on recruitment of multiple follicles for IVF/ET. 4th World Conference on in Vitro Fertilization, Melbourne, Australia, 1985, abstr 188Google Scholar
  20. 20.
    Loumaye E, Vankrieten L, Depreester S, Psalti I, de Cooman S, Thomas K: Hormonal changes induced by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development. Fertil Steril 1989;51:105–111PubMedGoogle Scholar
  21. 21.
    Parinaud J, Oustry P, Perineau M, Rème J-M, Monroziès X, Pontonnier G: Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program. Fertil Steril 1992;57:1265–1268PubMedGoogle Scholar
  22. 22.
    Balasch J, Jové CI, Moreno V, Civico S, Puerto B, Vanvell AJ: The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program. Fertil Steril 1992;58:991–994PubMedGoogle Scholar
  23. 23.
    Testart J, Forman R, Bellaish-Allart J, Volante M, Hazout A, Strubb N, Frydman R: Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotropin releasing hormone. Hum Reprod 1989;4:198–202PubMedGoogle Scholar
  24. 24.
    Brzyski GR, Jones GS, Jones WH, Oehninger S, Muasher JS: Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization. Fertil Steril 1991;55:119–124PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • B. C. Tarlatzis
    • 3
    • 2
  • G. Grimbizis
    • 3
  • F. Pournaropoulos
    • 2
  • J. Bontis
    • 1
    • 2
  • S. Lagos
    • 2
  • G. Pados
    • 1
    • 2
  • S. Mantalenakis
    • 3
    • 2
  1. 1.Second Department of OB/GYNAristotelian University of ThessalonikiThessalonikiGreece
  2. 2.IVF Centre “Geniki Kliniki,”ThessalonikiGreece
  3. 3.Department of Obstetrics-GynecologyAristotelian University of Thessaloniki, “Hippokration” General HospitalThessalonikiGreece

Personalised recommendations